Elleon’s Latest News and Events.
Announcing our HKSTP Partnership.
Keeping the momentum going strong as we strive forward into 2025, its with great pleasure we announce our admission into the Ideation program at Hong Kong Science and Technology Park. We’re excited to join the innovative ecosystem that HKSTP are fostering, and we’re excited to share our PhenoDot products with their scientific and entrepreneur community.
Asia Exhibition of
Innovations and Inventions
GOLD MEDAL WINNERS
Elleon were proud to attend the Entrepreneur Day 2024 event at the HKCEC this December. Even more proud to be asked to showcase PhenoDot as part of the Hong Kong Exporters’ Association and receive a gold medal award up against strong competition of 35 others in the category of health related innovations.
Elleon Biotech @ BIOHK2024
The exhibition hosted at the Hong Kong Conference and Exhibition Centre has been a huge success for the Elleon team and our PhenoDot technology. The feedback we’ve received has been overwhelmingly positive and the overall vibe around the potential for PhenoDot has been almost palpable.
From the whole Elleon team we would like to extend our thanks and appreciation to everyone who stopped by, or even just spent a moment to read through the booth material. We hope you all had a fruitful experience at the BIOHK2024 event either as a visitor or an exhibitor.
Lastly a huge thanks to the organising team for making the event run so smoothly and for all your tireless effort and help throughout the event.
Going Global with PCT filing
We’re proud to announce that filing of our patent will go through to PCT phase giving our PhenoDot tech patent protection in 157 countries. Now it’s time to make this amazing invention make a difference around the world.
Elleon Receive Government Funding for PhenoDot Patent.
Patent Application Grant Approved!
Hugely proud of the team’s efforts as today we received confirmation of our acceptance to the Patent Application Grant scheme. The time and effort paid off with a huge result seeing our patent receive government funding for the foreseeable future.